Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03690141 |
Title | A Study Examining the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer (CRPC) |
Recruitment | Terminated |
Gender | male |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Effector Therapeutics |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Yale Cancer Center | New Haven | Connecticut | 06510 | United States | Details | |
Northwestern University | Chicago | Illinois | 60611 | United States | Details | |
Kimmel Center at Johns Hopkins | Baltimore | Maryland | 21205 | United States | Details | |
Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
Washington University | Saint Louis | Missouri | 63110 | United States | Details | |
Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | United States | Details | |
The Urology Group | Cincinnati | Ohio | 45212 | United States | Details | |
Lancaster Urology | Lancaster | Pennsylvania | 17604 | United States | Details | |
Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | United States | Details | |
University of Washington | Seattle | Washington | 89109 | United States | Details |